BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37182452)

  • 21. Glycyrrhetinic acid alleviates acute lung injury by PI3K/AKT suppressing macrophagic Nlrp3 inflammasome activation.
    Wang K; Zhang Y; Cao Y; Shi Z; Lin Y; Chen Y; Zhao H; Liu X
    Biochem Biophys Res Commun; 2020 Nov; 532(4):555-562. PubMed ID: 32900490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gallic Acid Alleviates Gouty Arthritis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling.
    Lin Y; Luo T; Weng A; Huang X; Yao Y; Fu Z; Li Y; Liu A; Li X; Chen D; Pan H
    Front Immunol; 2020; 11():580593. PubMed ID: 33365024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
    Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
    Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Andrographolide Derivative AL-1 Ameliorates LPS-induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome and Lung Permeability.
    Li T; Zhang C; Wei Y; Zhong H; Shan L; Yu P; Wang Y; Xu L
    Curr Pharm Des; 2022; 28(30):2508-2517. PubMed ID: 35909279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
    Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lidocaine pretreatment attenuates inflammatory response and protects against sepsis-induced acute lung injury via inhibiting potassium efflux-dependent NLRP3 activation.
    Su K; Li XT; Hong FX; Jin M; Xue FS
    Inflamm Res; 2023 Dec; 72(12):2221-2235. PubMed ID: 37930383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
    Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
    Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fudosteine attenuates acute lung injury in septic mice by inhibiting pyroptosis via the TXNIP/NLRP3/GSDMD pathway.
    He G; Chen K; Wang H; Li X; Li W; Liu L; Chen J; Yang D; Hu J; Xu D; Wen F; Wang T
    Eur J Pharmacol; 2022 Jul; 926():175047. PubMed ID: 35609679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prim-O-glucosycimifugin attenuates liver injury in septic mice by inhibiting NLRP3 inflammasome/caspase-1 signaling cascades in macrophages.
    Liu LL; Yan X; Xue KY; Wang XM; Li LY; Chen HY; Li RL; Li H; Lan J; Xin JJ; Li X; Zhuo CL; Wu Z; Zhang D; Huang WJ; Wang YL; Li XY; Jiang W; Zhang HY
    Phytomedicine; 2022 Nov; 106():154427. PubMed ID: 36088791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitophagy-promoting miR-138-5p promoter demethylation inhibits pyroptosis in sepsis-associated acute lung injury.
    Liu F; Yang Y; Peng W; Zhao N; Chen J; Xu Z; Cui Y; Qian K
    Inflamm Res; 2023 Feb; 72(2):329-346. PubMed ID: 36538076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLR4 aggravates microglial pyroptosis by promoting DDX3X-mediated NLRP3 inflammasome activation via JAK2/STAT1 pathway after spinal cord injury.
    Wang J; Zhang F; Xu H; Yang H; Shao M; Xu S; Lyu F
    Clin Transl Med; 2022 Jun; 12(6):e894. PubMed ID: 35692100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xijiao Dihuang decoction combined with Yinqiao powder promotes autophagy-dependent ROS decrease to inhibit ROS/NLRP3/pyroptosis regulation axis in influenza virus infection.
    Deng D; Zhao M; Liu H; Zhou S; Liu H; You L; Hao Y
    Phytomedicine; 2024 Jun; 128():155446. PubMed ID: 38518643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
    Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
    J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paeoniflorin attenuates particulate matter-induced acute lung injury by inhibiting oxidative stress and NLRP3 inflammasome-mediated pyroptosis through activation of the Nrf2 signaling pathway.
    Zhou W; Zuo H; Qian Y; Miao W; Chen C
    Chem Biol Interact; 2024 May; 395():111032. PubMed ID: 38705442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TREM-1 aggravates chronic obstructive pulmonary disease development via activation NLRP3 inflammasome-mediated pyroptosis.
    Wang L; Chen Q; Yu Q; Xiao J; Zhao H
    Inflamm Res; 2021 Sep; 70(9):971-980. PubMed ID: 34374795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tanshinone IIA alleviates NLRP3 inflammasome-mediated pyroptosis in Mycobacterium tuberculosis-(H37Ra-) infected macrophages by inhibiting endoplasmic reticulum stress.
    Li Y; Fu Y; Sun J; Shen J; Liu F; Ning B; Lu Z; Wei L; Jiang X
    J Ethnopharmacol; 2022 Jan; 282():114595. PubMed ID: 34517060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome.
    Peng X; Yang T; Liu G; Liu H; Peng Y; He L
    Int Immunopharmacol; 2018 Dec; 65():448-457. PubMed ID: 30388519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antcin A alleviates pyroptosis and inflammatory response in Kupffercells of non-alcoholic fatty liver disease by targeting NLRP3.
    Ruan S; Han C; Sheng Y; Wang J; Zhou X; Guan Q; Li W; Zhang C; Yang Y
    Int Immunopharmacol; 2021 Nov; 100():108126. PubMed ID: 34492534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein C3 (ApoC3) facilitates NLRP3 mediated pyroptosis of macrophages through mitochondrial damage by accelerating of the interaction between SCIMP and SYK pathway in acute lung injury.
    Pu Z; Wang W; Xie H; Wang W
    Int Immunopharmacol; 2024 Feb; 128():111537. PubMed ID: 38232538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation.
    Yang HH; Duan JX; Liu SK; Xiong JB; Guan XX; Zhong WJ; Sun CC; Zhang CY; Luo XQ; Zhang YF; Chen P; Hammock BD; Hwang SH; Jiang JX; Zhou Y; Guan CX
    Theranostics; 2020; 10(11):4749-4761. PubMed ID: 32308747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.